StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Indegene Limited
NSE:INDGN.NS
Sector
Location
Market Cap
USD 1.59 B
Share Price
USD 6.62
Avg Daily Volume
1,225,236
Change (1 day)
0.16%
Change (1 year)
-0.07%
Change (YTD)
-6.09%
Indegene Limited Revenue for the year ending March 31, 2025: USD 332.25 M
Indegene Limited Revenue is USD 332.25 M for the year ending March 31, 2025, a 7.02% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
-
Indegene Limited Revenue for the year ending March 31, 2024 was USD 310.47 M, a 10.65% change year over year.
-
Indegene Limited Revenue for the year ending March 31, 2023 was USD 280.59 M, a 27.99% change year over year.
-
Indegene Limited Revenue for the year ending March 31, 2022 was USD 219.23 M, a 66.13% change year over year.
-
Indegene Limited Revenue for the year ending March 31, 2021 was USD 131.96 M, a 54.51% change year over year.
Competitors
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Novo Nordisk A/S
USD 69.09
NOVO-B.CO
-1.99
-2.80%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
Novartis AG
USD 122.10
NOVN.SW
-1.46
-1.18%
Abbott Laboratories
USD 133.70
ABT
-0.74
-0.55%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Vertex Pharmaceuticals Incorporated
USD 459.41
VRTX
-0.21
-0.05%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%
Chugai Pharmaceutical Co., Ltd.
USD 47.25
4519.T
-1.65
-3.37%
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
CSL Limited
USD 160.25
CSL.AX
-0.71
-0.44%
Zoetis Inc.
USD 157.05
ZTS
-2.13
-1.34%
Regeneron Pharmaceuticals, Inc.
USD 538.11
REGN
-9.25
-1.69%
MERCK Kommanditgesellschaft auf Aktien
USD 128.02
MRK.DE
-2.92
-2.23%
Lonza Group AG
USD 698.01
LONN.SW
-7.45
-1.06%
Key Data
| Date | Revenue | Revenue | Gross Profit | Operating Income |
|---|
Competitors
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Novo Nordisk A/S
USD 69.09
NOVO-B.CO
-1.99
-2.80%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
Novartis AG
USD 122.10
NOVN.SW
-1.46
-1.18%
Abbott Laboratories
USD 133.70
ABT
-0.74
-0.55%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Vertex Pharmaceuticals Incorporated
USD 459.41
VRTX
-0.21
-0.05%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%
Chugai Pharmaceutical Co., Ltd.
USD 47.25
4519.T
-1.65
-3.37%
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
CSL Limited
USD 160.25
CSL.AX
-0.71
-0.44%
Zoetis Inc.
USD 157.05
ZTS
-2.13
-1.34%
Regeneron Pharmaceuticals, Inc.
USD 538.11
REGN
-9.25
-1.69%
MERCK Kommanditgesellschaft auf Aktien
USD 128.02
MRK.DE
-2.92
-2.23%
Lonza Group AG
USD 698.01
LONN.SW
-7.45
-1.06%